Yahoo Finance

Ehave Files 6-K Disclosing LOI Details For The Acquisition Of Moksha Digital Software

MIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced ...
Yahoo Finance

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

MIAMI, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, today issued a ...
Nasdaq

Ehave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping Technology

Ehave will partner with Brain Scientific Inc. to leverage both data and AI to correlate biomarkers for the Identification of Chronic pain, Depression (major and persistent), PTSD, Bipolar disorder, ...
The Globe and Mail

Ehave To Release Vaccine Passport As Part Of Its Medical Passport

MIAMI, June 03, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced ...
The National Law Review

Ehave Snaps Up AI Headhunter for $10M, Signaling Commitment to AI

AIHeadHunter Slashes Hiring Time by 85% and Costs by 70% — Ehave’s Vision to Incubate Scalable Platforms Tackling Real-World Inefficiencies Comes to Life in a $700 Billion Industry Projected to Top $2 ...
Nasdaq

Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological Vitals From Vastmindz; Prepares To Run Testing ...

Proprietary computer vision technology will provide the Ehave Dashboard and Ehave Medical App with the ability to extract information about changes in light absorption on an individual’s facial skin ...
Business Insider

Psychedelic Partnership Reached, Ehave Inc. and Brain Scientific Sign Memorandum of Understanding to Map Brain Response to Psychedelic Treatment, Collaborate in the Development ...

Ehave, Inc. to leverage data and AI to correlate biomarkers for the identification of psychedelic drug administration as a treatment for Chronic pain, Depression (major and persistent), PTSD, Bipolar ...
Business Insider

Ehave Announces Deployment of Machine Learning to Deliver Patient Insights for Mental Healthcare and Medical Cannabis

TORONTO, Dec. 7, 2017 /CNW/ -- Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced that the ...
Finanznachrichten

Ehave, Inc. Appoints Dr. Mark Braunstein as Chief Psychedelic Officer

Dr. Braunstein is recognized worldwide in Psychedelic Psychiatry, which entails treating psychiatric disorders with psychedelics MIAMI, FL / ACCESSWIRE / March 27, 2020 / Ehave, Inc., (OTC PINK:EHVVF) ...
Stockhouse

Ehave Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly

Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental and overall health of individuals. MIAMI, Sept. 07, 2021 ...
The Globe and Mail

Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological Vitals From Vastmindz; Prepares To Run Testing ...

MIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has ...
Morningstar

Ehave Snaps Up AI Headhunter for $10M, Signaling Commitment to AI

MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”) today announced the acquisition of AIHeadHunter, an artificial intelligence-powered recruitment platform, ...